Tag: clinical trials
-
Psychedelic Therapy Company Raises $80M in New Funds
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round.
-
Infographic – Biomedical Innovation Gains Continue
Two statistical indicators provide more evidence that innovations in health and medicine are continuing their sharp upward climb.
-
Sanofi Acquires mRNA Developer in $3.2B Deal
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator.
-
Trial Tests Psychedelic Drug Safety, Chemical Activity
A clinical trial is underway that tests an hallucinogenic compound among healthy adults as a potential treatment for mental health disorders.
-
FDA Clears Stem Cell Trial for Multiple Sclerosis
The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis.
-
ALS Drug Maker Gains $135M in New Funds
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round.
-
Pooled Saliva Tests Detect Covid-19 in Schools
Combining commercial saliva tests to speed detection of the SARS-CoV-2 virus in schools is shown as accurate as individual gold-standard nasal swab tests.
-
Trial to Test Antibody Drug for Alzheimer’s Prevention
Eli Lilly and Company is partnering with an Alzheimer’s disease research center to test a synthetic antibody for preventing the disorder in at-risk individuals.
-
Immune Cell Cancer Biotech Gains $172M in New Funds
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round.
-
Trial Underway for Crispr Lymphoma Therapy
A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr.